Cellectar, Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors (NCT00925275) | Cellectar, Inc | 2009-06-01 |
Track Cellectar, Inc automatically
Every clearance here is in the API, with alerts when new ones post.